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The phagocytosis and elimination of microbial 
pathogens by macrophages is an evolutionarily 
conserved component of the innate immune sys-
tem in all metazoa from humans to organisms as 
primitive as starfish (1, 2). In mammals, it is now 
recognized that macrophages, beyond their anti-
microbial properties, can regulate both innate and 
adaptive immune responses in multiple inflam-
matory diseases, including mouse models of air-
way inflammation, psoriasis, inflammatory bowel 
disease, and atherosclerosis (3–7).
Macrophage differentiation and function are 
governed by numerous cell-extrinsic factors that 
include chemokines, cytokines, and toll-like re-
ceptor ligands (8). For example, classically acti-
vated macrophages differentiate in response to 
proinflammatory cytokines such as IFN- and 
microbial stimuli including LPS and CpG. Their 
production of proinflammatory mediators and 
microbicidal compounds, such as nitric oxide 
and reactive oxygen species, is essential for the 
elimination of intracellular pathogens including 
Leishmania and Salmonella (9). In contrast, expo-
sure to the Th2 cytokines IL-4 and IL-13 pro-
motes the differentiation of alternatively activated 
macrophages (AAMacs) that are defined by the 
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Differentiation and recruitment of alternatively activated macrophages (AAMacs) are hall-
marks of several inflammatory conditions associated with infection, allergy, diabetes, and 
cancer. AAMacs are defined by the expression of Arginase 1, chitinase-like molecules, and 
resistin-like molecule (RELM) /FIZZ1; however, the influence of these molecules on the 
development, progression, or resolution of inflammatory diseases is unknown. We describe 
the generation of RELM-–deficient (Retnla/) mice and use a model of T helper type 2 
(Th2) cytokine-dependent lung inflammation to identify an immunoregulatory role for 
RELM-. After challenge with Schistosoma mansoni (Sm) eggs, Retnla/ mice developed 
exacerbated lung inflammation compared with their wild-type counterparts, characterized 
by excessive pulmonary vascularization, increased size of egg-induced granulomas, and 
elevated fibrosis. Associated with increased disease severity, Sm egg–challenged Retnla/ 
mice exhibited elevated expression of pathogen-specific CD4+ T cell–derived Th2 cytokines. 
Consistent with immunoregulatory properties, recombinant RELM- could bind to macro-
phages and effector CD4+ Th2 cells and inhibited Th2 cytokine production in a Bruton’s 
tyrosine kinase–dependent manner. Additionally, Retnla/ AAMacs promoted exaggerated 
antigen-specific Th2 cell differentiation. Collectively, these data identify a previously unrec-
ognized role for AAMac-derived RELM- in limiting the pathogenesis of Th2 cytokine-
mediated pulmonary inflammation, in part through the regulation of CD4+ T cell responses.
© 2009 Nair et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Collectively, these studies reveal a previously unrecognized 
role for AAMac-derived RELM- in limiting Th2 cytokine-
dependent inflammatory responses in the lung through 
immunoregulatory effects on CD4+ T cell responses.
RESULTS
Generation and characterization of Retnla/ mice
Retnla/ mice were generated by homologous recombina-
tion where all four exons of RELM- were replaced by a lacZ 
reporter gene and a neomycin selection cassette (Fig. 1 A). 
Confirmation of the deletion was determined by genotyping 
PCR analysis (Fig. 1 A). Naive Retnla/ mice were healthy 
and fertile and did not exhibit detectable impairment in im-
mune cell development or composition of lymphoid com-
partments. This included equivalent frequencies of CD4+, 
CD8+, and CD4+CD8+ cells in the thymi of WT and Retnla/ 
mice (Fig. 1 B). Natural killer cells (Fig. 1 C, DX5+), B cells 
(Fig. 1 D, B220+), T cells (Fig. 1 D, CD3+), CD4+ (Fig. 1 E), 
and CD8+ (Fig. 1 E) cells were also present in comparable fre-
quencies in WT and Retnla/ mice in the peripheral LNs and 
spleen. CD4+ T cells from naive WT and Retnla/ mice also 
exhibited equivalent basal expression of CD62L, CD44, and 
CD69 (Fig. 1, F and G), indicating no aberrant CD4+ T cell 
activation. Combined analysis of four WT and four Retnla/ 
mice revealed that there were no significant differences in all 
the compartments (Fig. S1). Finally, RELM- deficiency did 
not affect resident macrophage populations, as naive Retnla/ 
mice exhibited equivalent proportions of macrophages recov-
ered from the peritoneal cavity (PEC) and bronchoalveolar la-
vage (BAL) fluid compared with WT counterparts (Fig. 1 H). 
Macrophages from WT and Retnla/ mice also exhibited 
equivalent LPS-induced expression of inducible nitric oxide 
synthase (Nos2A) messenger RNA (mRNA) and production 
of nitric oxide, IL-12/23p40, and IL-6 (Fig. 1 I), demonstrat-
ing that there was no inherent defect in the innate activation 
of Retnla/ macrophages.
RELM- is expressed by mannose receptor+ AAMacs  
in Sm egg-induced pulmonary granulomas
Given previous reports of elevated expression of AAMac-de-
rived RELM- in Th2 cytokine-associated pulmonary inflam-
mation (12, 27, 28, 33), we used a model of Th2 cytokine- 
dependent inflammation in the lung to investigate the potential 
functions of RELM- in the pathogenesis of pulmonary in-
flammation. After i.p. sensitization and i.v. challenge, Sm eggs 
are transported into the lung tissue via the pulmonary arteries 
where they become trapped within the lung parenchyma by 
the formation of Th2 cytokine-dependent granulomas com-
posed of AAMacs, eosinophils, and lymphocytes (19, 27). 
Quantitative real-time PCR of whole lung tissue isolated 
from C57BL/6 mice at day 8 after Sm egg challenge revealed 
a 10-fold induction of RELM- (Retnla) mRNA expres-
sion levels in comparison with lung tissue from naive mice 
(Fig. 2 A). Sm egg challenge also induced robust RELM- 
protein secretion, which was detected by Western blot anal-
ysis of the BAL fluid (Fig. 2 B).
expression of a panel of signature genes including Arginase 1, 
chitinase-like molecules (Ym1/2 and AMCase), and resistin-
like molecule (RELM)  (10–13). Although the recruitment 
of AAMacs is a characteristic feature of a wide range of inflam-
matory conditions associated with parasite infection, allergy, 
diabetes, and cancer (7, 14–17), their potential roles in influenc-
ing the development, severity, or resolution of inflammatory 
responses have remained controversial. For example, several 
beneficial functions for AAMacs have been proposed, which 
include enhancing host defense against parasite infection (14, 
18), the amelioration of diabetes through the regulation of nu-
trient homeostasis (16), and promotion of tissue repair after in-
jury (10, 19, 20). In contrast, tumor-associated AAMacs and 
those that are recruited in Th2 cytokine-mediated allergic re-
sponses have been implicated in the exacerbation of disease (7, 
17, 21–23). The putative pleiotropic functions of AAMacs may 
relate to heterogeneity in expression of signature molecules such 
as Arginase 1, chitinase-like molecules, and RELM-; how-
ever, to date there has been no systematic analysis of the roles of 
these molecules in the regulation of inflammatory responses.
In this study, we examined the functions of RELM- in 
Th2 cytokine-mediated lung inflammation. RELM- be-
longs to a family of small cysteine-rich secreted proteins that 
are conserved in mammals (24–26) and it exhibits a broad 
pattern of expression in hematopoietic and nonhematopoietic 
cells (11, 24–26). Elevated expression of RELM- in mouse 
models of pulmonary inflammation (24, 27–29) and increased 
expression of the related human protein resistin in inflamma-
tory diseases in patients (30) implicate a putative role in influ-
encing innate and adaptive immune responses. However, 
previous studies have identified contrasting effects of RELM- 
in regulating inflammation. Consistent with a role in promot-
ing pulmonary inflammation, in vitro studies showed that 
recombinant RELM- (rRELM-) could drive proliferation 
and growth factor expression in lung fibroblast cell lines (31, 
32). In contrast, rRELM- was reported to antagonize the 
effects of nerve growth factor, a protein associated with the 
exacerbation of allergic pulmonary responses (33), suggesting 
that RELM- may negatively regulate Th2 cytokine-medi-
ated inflammation in the lung.
To investigate these paradoxical findings, we used mice 
deficient in RELM- (Retnla/) in an in vivo model of Th2 
cytokine-dependent pulmonary inflammation and fibrosis (19, 
27). In response to challenge with eggs from the helminth par-
asite Schistosoma mansoni (Sm), Retnla/ mice exhibited more 
severe pulmonary inflammation and exacerbated egg-induced 
granuloma formation associated with significantly elevated ex-
pression of Th2 cytokines and Th2 cytokine-responsive genes 
compared with WT mice. In Th2 cell differentiation assays, 
rRELM- could bind to macrophages and effector CD4+ Th2 
cells and specifically inhibited expression of Th2 cytokines. 
This suppressive effect was dependent on Bruton’s tyrosine 
kinase (BTK) signaling. Conversely, Retnla/ AAMacs pro-
moted exaggerated antigen-specific Th2 cytokine production 
compared with WT AAMacs, identifying a role for endoge-
nous RELM- in regulating the expression of Th2 cytokines. 
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Th2 cytokines (12, 20, 24, 27), costaining for IL-4R revealed 
RELM-+IL-4R+ cells within the granuloma (Fig. 2 G, red). 
To examine whether the mannose receptor+ cells observed in 
the granulomas were macrophages, we dissociated cells from the 
lungs of Sm egg-challenged mice and stained for the mannose re-
ceptor, for F4/80, and for CD11c, a marker which is elevated in 
lung macrophages (34, 35). Although there was low surface ex-
pression of F4/80 in cells from the lung (Fig. S2 A), which is 
consistent with previous studies (36), the majority of CD11c+ 
cells also costained with the mannose receptor (Fig. S2 B), sug-
gesting that the mannose receptor+CD11c+ cells are AAMacs.
To quantify the relative frequencies of RELM-+ AAMacs 
and eosinophils, flow cytometric analysis of cells dissociated from 
To investigate the cellular sources of RELM-, immunoflu-
orescent (IF) staining with an anti–RELM- antibody was per-
formed on lung sections from naive and Sm egg-challenged WT 
mice. In response to Sm egg challenge, RELM- protein was 
produced by airway epithelial cells (Fig. 2 C, middle) and in cells 
recruited into the egg-induced granuloma (Fig. 2 C, right). 
Costaining for CC10, a marker for secretory Clara cells which 
line the airway epithelium, confirmed RELM- expression by 
Clara cells (Fig. 2 D). In the pulmonary granuloma, costaining 
with the mannose receptor (Fig. 2 E, red) and siglec-F (Fig. 2 F, 
red) revealed that mannose receptor+ AAMacs and siglec-F+ eo-
sinophils were the cellular sources of RELM-. Consistent with 
studies demonstrating that Retnla gene expression is responsive to 
Figure 1. Generation and characterization of Retnla/ mice. (A) Schematic diagram of the Retnla locus in WT and Retnla/ mice and primers 
used to confirm the genotypes by PCR. (B–G) Frequency of CD4, CD8, B lymphocytes, and NK cells (DX5+) in the thymi, spleen, and LN of naive WT and 
Retnla/ mice, and CD4+ T cell surface expression of CD62L, CD44, and CD69. (H) Frequency of resident macrophages from the PEC or the BAL of naive 
WT and Retnla/ mice. Results (± SEM of four animals) are representative of two independent experiments of a total number of 9–10 individual animals 
per group. (I) Real-time PCR analysis of Nos2A expression, and secretion of nitric oxide, IL-12/23p40, and IL-6 by control or LPS-stimulated WT and 
Retnla/ macrophages. Results (mean ± SEM) are representative of two independent experiments.
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vestigate whether RELM- could influence Sm egg-induced 
pulmonary inflammation and granuloma formation, WT and 
Retnla/ mice were challenged with Sm eggs. Analysis of 
hematoxylin and eosin (H&E)–stained lung sections isolated 
from naive WT and Retnla/ mice revealed no pathological 
change in the absence of RELM- in steady-state conditions 
(Fig. 3 A). This included comparable architecture of the lung 
parenchyma in WT and Retnla/ mice, with equivalent al-
veolar spaces, endothelial vessel formation (Fig. 3 A, black ar-
rowheads), and bronchiole development (Fig. 3 A, white 
arrowheads). At day 8 after Sm egg challenge, WT mice ex-
hibited modest airway epithelial cell hyperplasia and increased 
arterial inflammation characterized by thickening of the endo-
thelium (Fig. 3 B, top, arrowhead). Higher power analysis re-
vealed a perivascular infiltration of lymphocytes, eosinophils, 
and activated macrophages (Fig. 3 C, top). Strikingly, in com-
parison with WT mice, Sm egg-challenged Retnla/ mice 
exhibited exacerbated pulmonary inflammation (Fig. 3 B, 
bottom). This included severe arterial inflammation (Fig. 3 B, 
bottom, arrowhead), characterized by increased cellularity 
within the arterial lumen, hypertrophy of the endothelium, and 
the accumulation of lymphocytes, eosinophils, and activated 
macrophages around the vessel wall (Fig. 3 C, bottom).
Histological examination of the egg-induced pulmonary 
granulomas in WT mice revealed the formation of compact 
granulomas around the egg, composed of red blood cells, 
lung tissue of naive and Sm egg-challenged mice was performed. 
Intracellular staining for RELM- in cells from dissociated lungs 
revealed a ninefold increase in the frequency of RELM-+ cells 
after Sm egg challenge (Fig. 2 H). Of the RELM-+ cells, 38 ± 
4% were mannose receptor+ AAMacs, whereas 20 ± 2% were 
siglec-F+ eosinophils (Fig. 2 H, right). Therefore, the frequency 
of RELM-+ AAMacs was twofold higher than that of eosino-
phils. Quantification of the total number of RELM-+ cells 
within the lung confirmed elevated numbers of RELM-+ cells 
(Fig. S2 C), and differential staining for AAMacs and eosinophils 
demonstrated increased RELM-+ AAMacs compared with 
RELM-+ eosinophils (Fig. S2 D). Staining for CD45 revealed 
that the remaining mannose receptorsiglec-F cells (double 
negative [DN]) were not hematopoietically derived, as they did 
not express CD45 (Fig. 2 I). Together with the IF staining, 
which revealed RELM- expression by CC10+ cells, this DN 
cell population likely represents lung-resident Clara cells. Col-
lectively, these results demonstrate that after Sm egg challenge in 
the lung, the dominant cellular sources of RELM- are resident 
airway epithelial cells and infiltrating AAMacs within the egg-
induced granulomas.
Retnla/ mice develop exacerbated pulmonary 
inflammation and fibrosis after exposure to Sm eggs
RELM-+ AAMacs have been implicated in both the promo-
tion and inhibition of inflammatory responses (7, 18). To in-
Figure 2. RELM- is expressed after Sm egg challenge. (A) Lung Retnla expression in naive and Sm egg-challenged C57BL/6 mice. *, P < 0.05.  
(B) Western blot analysis of the BAL fluid from naive or day 8 Sm egg-challenged mice. (C) IF staining of lung sections for RELM- (green) and DAPI (blue). 
(D–G) Costaining with CC10 (D; red), the mannose receptor (E; red), siglec-F (F; red), or IL-4R (G; red). Arrowheads indicate costaining of antibodies with 
RELM-. (H) Flow cytometry plots (forward scatter [FSC] vs. RELM-) of lung cells from naive and Sm egg-challenged mice, and mannose receptor and 
siglec-F expression by RELM-–positive cells. *, P < 0.05. (I) CD45 expression by the mannose receptorsiglec-F population (DN; red) and mannose re-
ceptor+ or siglec-F+ cells (single positive [SP]). Bars, 50 µm. Results (± SEM of three to four animals) are representative of two to three independent ex-
periments (A–H; n = 9–12) and one experiment (I; n = 4).
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Figure 3. Retnla/ mice exhibit exacerbated Sm egg-induced pulmonary inflammation. (A–C) H&E-stained lung sections from naive and Sm 
egg-challenged WT and Retnla/ mice. Black arrowheads, pulmonary arteries; white arrowheads, bronchiole development. P, lung parenchyma; LI, leuko-
cyte infiltrate; E, endothelium. (D) H&E-stained sections of granulomas from Sm egg-challenged WT and Retnla/ mice. (E) Size of granulomas sur-
rounding Sm eggs from WT and Retnla/ mice; n = 30 granulomas from a total of three mice per group. Results are representative of at least two 
independent experiments with three to four mice per group (n = 6–8 animals per genotype). (F) IF staining of granulomas for the mannose receptor (red) 
and DAPI (blue). White arrowheads depict mannose receptor+ cells. (G) Flow cytometric quantification of mannose receptor+ cells from dissociated lung 
tissue. (H) Lung Arg1 and ChiA expression in naive and Sm egg-challenged WT and Retnla/ mice. ***, P < 0.001; *, P < 0.05. (I) Masson’s trichrome-
stained granulomas from WT and Retnla/ mice. White arrowheads, collagen stain. Bars, 50 µm. Results (mean ± SEM of three to four mice) are repre-
sentative of two to three independent experiments (n = 6–10 per group).
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draining mediastinal LNs (Fig. 4 A), similar frequencies of lym-
phocytes in the BAL and lung tissue (Fig. S3, A and B), and an 
equivalent increase in the frequency of proliferating LN CD4+ 
T cells (Fig. 4 B) at day 8 after challenge. Furthermore, ex vivo 
analysis of cytokine production by mediastinal LN cells re-
vealed that Sm egg challenge induced similar up-regulation in 
the frequency of IFN-+CD4+ T cells in WT and Retnla/ 
mice (Fig. 4 C). However, although Sm egg-challenged WT 
mice exhibited a fourfold increase in the frequency of IL-13+ 
CD4+ T cells in comparison with naive control mice (Fig. 4 D, 
top), the frequency of IL-13+CD4+ T cells isolated from the 
draining LN of Sm egg-challenged Retnla/ mice was in-
creased ninefold over naive mice (Fig. 4 D, bottom). In addi-
tion to the elevated frequency of IL-13+CD4+ T cells, Sm 
egg-challenged Retnla/ mice exhibited a significantly in-
creased frequency of IL-5+CD4+ T cells in comparison with 
WT mice (Fig. 4 E), and they exhibited increased levels of Il4 
mRNA (Fig. S3 C). Although there were equivalent frequen-
cies of eosinophils in the BAL and lungs of Sm egg-challenged 
WT and Retnla/ mice (Fig. S3, A and B), the increased fre-
quency in IL-5+CD4+ T cells in the egg-challenged Retnla/ 
mice correlated with elevated Sm egg-induced expression of 
Ccl11 (eotaxin 1) and Ccl24 (eotaxin 2) mRNA in the absence 
of RELM- (Fig. S3 D).
To measure parasite-specific Th2 cytokine production, 
draining LN cells isolated from naive and Sm egg-challenged 
WT and Retnla/ mice were restimulated for 48 h with Sm 
egg antigen. Strikingly, LN cells from Sm egg-challenged 
Retnla/ mice secreted significantly higher levels of antigen-
specific IL-4 (Fig. 4 F), IL-13 (Fig. 4 G), and IL-5 (Fig. 4 H) 
than cells isolated from Sm egg-challenged WT mice. This in-
cluded an over fivefold increase in IL-4 and IL-13 production 
and a twofold increase in IL-5 production. Consistent with the 
elevated Th2 cytokine response, Sm egg-challenged Retnla/ 
mice also exhibited increased antigen-specific IgG1 antibody 
titers (Fig. 4 I) and significantly elevated total IgE levels com-
pared with WT mice (Fig. 4 J). Collectively, these results sug-
gest that the production of RELM- after Sm egg challenge 
may down-regulate Th2 cytokine responses.
RELM- inhibits production of Th2 cytokines
Given that the deletion of RELM- resulted in enhanced 
expression of Th2 cytokines and exacerbated lung inflamma-
tion and fibrosis after Sm egg challenge, we sought to test the 
hypothesis that RELM- may act directly on immune cells 
to modulate Th2 cell differentiation by using an in vitro 
CD4+ T cell differentiation assay. CFSE-labeled splenocytes 
from naive C57BL/6 mice were unstimulated or polyclon-
ally stimulated with -CD3/-CD28 under neutral condi-
tions or conditions permissive for Th2 cell differentiation in 
the absence or presence of recombinant RELM- (rRELM-). 
Treatment with rRELM- had no effect on T cell acti-
vation, as assessed by the surface expression of CD25 or 
CD69 on CD4+ T cells (Fig. 5 A). Additionally, rRELM- 
had no effect on T cell proliferation under neutral or Th2-
permissive conditions, as examined by CFSE dilution 3 d 
activated macrophages, lymphoid cells, granulocytes, and 
multinucleated giant cells (Fig. 3 D, left). In contrast, Sm 
egg-challenged Retnla/ mice exhibited more severe in-
flammation surrounding the egg (Fig. 3 D, right), which in-
cluded a significant increase in the mean area of inflammation 
surrounding the granuloma (Fig. 3 E). Collectively these 
data indicate that RELM- deficiency results in exacerbated 
Sm egg-induced pulmonary inflammation.
AAMac responses are enhanced in Sm egg-challenged 
Retnla/ mice
Given that RELM- is a signature gene of AAMacs, we hy-
pothesized that RELM- deficiency may affect expression of 
other AAMac-derived genes or the recruitment or function of 
AAMacs. IF staining of mannose receptor+ cells in the granulo-
mas from Sm egg-challenged WT and Retnla/ mice indicated 
that there was no impairment in the recruitment of mannose 
receptor+ AAMacs in the absence of RELM- (Fig. 3 F, red), 
and quantification of the mannose receptor+ cells by flow cyto-
metric analysis of dissociated lung tissue revealed equivalent fre-
quencies of mannose receptor+ AAMacs in the Sm egg-challenged 
WT and Retnla/ mice (Fig. 3 G). To examine AAMac re-
sponses after Sm egg challenge, lungs from naive and Sm egg-
challenged WT and Retnla/ mice were analyzed for expression 
of the AAMac genes Arg1 (Arginase 1) and ChiA (acidic mam-
malian chitinase) by real-time PCR. In WT mice, Sm egg chal-
lenge resulted in a 17-fold induction of Arg1 over naive controls 
(Fig. 3 H). In contrast, there was a >70-fold induction of Arg1 in 
Sm egg-challenged Retnla/ mice. Furthermore, although Sm 
egg challenge of WT mice resulted in a fourfold induction of 
ChiA, we observed a ninefold induction of ChiA in Retnla/ 
mice (Fig. 3 H). The increased recruitment of mannose receptor+ 
cells into the granulomas, coupled with significant increases in 
levels of Arg1 and ChiA mRNA in Retnla/ mice, indicates that 
the AAMac responses are elevated in the absence of RELM-. 
Given that one proposed function of AAMacs is to promote 
fibrosis (19, 37), in part through mediating collagen synthesis, 
we tested the hypothesis that Retnla/ mice may exhibit differ-
ences in collagen deposition in the Sm egg-induced granulo-
mas. Consistent with elevated AAMac responses, Masson’s 
trichrome staining of the lung sections revealed that Retnla/ 
mice exhibited elevated collagen deposition in the egg-induced 
granuloma in comparison with WT mice (Fig. 3 I, arrowheads). 
Together, these data demonstrate that Sm egg-induced AAMac 
responses were increased in the absence of RELM-.
Retnla/ mice exhibit elevated Sm egg-induced  
CD4+ Th2 cell responses
Th2 cytokines play an essential role in Sm egg-induced pulmo-
nary granuloma formation (19). Given the exacerbated Sm 
egg-induced pulmonary inflammation and granuloma forma-
tion in the absence of RELM-, we sought to determine 
whether Retnla/ mice exhibited dysregulated CD4+ T cell 
responses in comparison with WT mice after Sm egg chal-
lenge. In comparison with naive controls, Sm egg-challenged 
WT and Retnla/ mice showed equivalent expansion of the 
JEM VOL. 206, April 13, 2009 
ARTICLE
943
cytes from TLR-4 hyporesponsive mice (C3H/HeJ) (Fig. 5 
F). In addition, rRELM- derived from a mammalian ex-
pression system also inhibited expression of Th2 cytokines. 
Transfection of 293T cells with a control (enhanced GFP 
[eGFP]) or a Retnla-expressing plasmid under the control of 
the CMV promoter was used for the generation of superna-
tant enriched for mammalian-derived rRELM-. No band 
was detected in the 72-h supernatant from 293T cells trans-
fected with the control eGFP plasmid, indicating specificity 
in Retnla expression and detection by Western blotting. In 
contrast, analysis of supernatants from Retnla-transfected cells 
revealed detectable RELM- by 48 h and maximal expres-
sion at 72 h, with an estimated concentration of 100 ng/ml 
(Fig. 5 G, top). Addition of the mammalian-derived rRELM- 
resulted in the significant reduction in IL-5 and IL-13 pro-
duction by splenocytes stimulated with -CD3/-CD28 
after stimulation (Fig. 5 B). However, rRELM- treatment 
resulted in a dose-dependent decrease in IL-4 and IL-5 pro-
duction by splenocytes activated both under neutral and Th2-
polarizing conditions (Fig. 5, C and D). Consistent with the 
in vivo findings with Sm egg challenge of WT and Retnla/ 
mice (Fig. 4 C), the inhibitory effect of RELM- was specific 
to Th2 cytokines, as there was no difference in IFN- pro-
duction in response to rRELM- treatment (Fig. 5 E). The 
effect of RELM- in modulating expression of Th2 cyto-
kines, but not IFN-, was strikingly different from our previ-
ous study on the related protein RELM-, which promoted 
IFN- production (38). These findings indicate pleiotropy in 
the functions of the RELM protein family. The suppressive 
effect of rRELM- was not caused by LPS contamination of 
the bacterially derived rRELM- because rRELM-–in-
duced inhibition of IL-5 and IL-13 was observed in spleno-
Figure 4. Exacerbated expression of Th2 cytokines in Sm egg-challenged Retnla/ mice. (A) Cell counts from the draining LN of naive or Sm 
egg-challenged WT and Retnla/ mice. (B) Flow cytometric analysis of CD4+ T cell incorporation of BrdU. (C–E) Ex vivo flow cytometric analysis of CD4+ 
T cell–derived IFN- (C), IL-13 (D), and IL-5 (E). (F–H) Antigen-specific secretion of IL-4 (F), IL-13 (G), and IL-5 (H) by draining LN cells. (I) Antigen-specific 
IgG1 antibody titers. (J) Serum IgE levels. ***, P < 0.001; **, P < 0.01; *, P < 0.05. Results (mean ± SEM of two to four mice per group) are representative of 
three independent experiments (naive, n = 6; Sm egg-challenged, n = 11).
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inflammation in the absence of RELM-, these data indicate 
that RELM- can modulate Th2 cytokine production 
through direct effects on hematopoietic cells.
under Th2-permissive conditions in comparison with control 
supernatant (Fig. 5 G, bottom). Collectively with the in vivo 
results demonstrating elevated Th2 cytokine-induced lung 
Figure 5. RELM- negatively regulates Th2 cytokine production by -CD3/-CD28–stimulated splenocytes. (A) Expression of CD25 and CD69 
by CD4+ T cells from untreated (UT) or -CD3/-CD28–stimulated splenocytes in the presence of rRELM- (filled histogram). (B) Frequency of CFSE-dim 
CD4+ T cells from untreated splenocytes or splenocytes stimulated with -CD3/-CD28 (filled histogram) under neutral or Th2-permissive conditions in 
the presence rRELM-. (C–E) Supernatants were analyzed for IL-4 (C), IL-5 (D), and IFN- (E) secretion. (F) C3H/HeJ splenocytes were untreated or stimu-
lated with -CD3/-CD28 under Th2-permissive conditions in the presence of 5 µg/ml rRELM-, followed by measurement of IL-5 and IL-13 secretion. 
(G) RELM- Western blotting of supernatants (sup) from 293T cells transfected with a control eGFP plasmid or the Retnla plasmid. WT splenocytes were 
untreated or stimulated with -CD3/-CD28 under Th2-permissive conditions in the presence of 72-h sup at a 1:1 ratio followed by measurement of IL-5 
and IL-13 secretion. Results (mean ± SEM; ***, P < 0.001; *, P < 0.05) are representative of two to three independent experiments.
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cells and the mean fluorescent intensity, in contrast to 
Retnla/ macrophages where there was no detectable RELM- 
protein (Fig. 6 B). To investigate if RELM- deficiency al-
tered the expression of other AAMac signature genes, untreated 
or IL-4–treated WT and Retnla/ BMMacs were examined 
for expression of Arg1 and Ym1 mRNA by real-time PCR. 
WT and Retnla/ AAMacs showed comparable up-regula-
tion of Arg1 and Ym1 (Fig. 6 C), which is consistent with no 
defect in AAMac differentiation in Retnla/ mice observed 
in vivo (Fig. 3 F). Further, there was no difference between 
WT and Retnla/ AAMacs in the surface expression of MHC 
class II and PDL2 (Fig. 6 D), both of which are up-regulated 
in AAMacs in response to IL-4 (39, 40).
To address the role of AAMac-derived RELM- in mod-
ulating antigen-specific T cell responses, WT and Retnla/ 
Retnla/ AAMacs promote Th2 cytokine production  
by CD4+ T cells
Because AAMacs are a source of RELM- in the lung and 
rRELM- can inhibit Th2 cytokine production, we sought 
to test whether AAMac-derived RELM- could influence T 
cell function in an in vitro T cell proliferation and differentia-
tion assay. WT and Retnla/ AAMacs were generated by IL-4 
treatment of BM-derived macrophages (BMMacs) from WT 
and Retnla/ mice. Alternative activation of WT BMMacs 
resulted in a 20-fold induction of Retnla mRNA levels in con-
trast with untreated or IL-4–treated Retnla/ BMMacs, 
where there was no detectable Retnla mRNA (Fig. 6 A). Costain-
ing for the mannose receptor and RELM- revealed that WT 
mannose receptor+ AAMacs exhibited elevated RELM- 
protein expression, both in the frequency of RELM-+ 
Figure 6. Retnla/ AAMacs promote exaggerated production of Th2 cytokines by CD4+ T cells. (A and B) Retnla expression by WT or Retnla/ 
UT (cont) or AAMacs was measured by real-time PCR (fold induction over actin; A) and intracellular flow cytometry (B). (C) Arg1 and Ym1 expression (fold 
induction over cont) was measured. ***, P < 0.001. (D) Surface expression of MHC class II and PDL2 by WT and Retnla/ cont (dashed line) or AAMac 
(solid line). (E–H) Control or OVA-pulsed WT or Retnla/ AAMacs were cocultured with CFSE-labeled OVA-specific CD4+ T cells. (E) Frequency of CFSE-
dim CD4+ T cells (italics). (F and G) Frequency of IFN-+ and IL-4+ CFSE-dim CD4+ T cells (italics). (H) Supernatants were recovered for measurement of 
IFN-, IL-4, and IL-5 secretion. Results (mean ± SEM) are representative of two independent experiments.
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OVA-pulsed WT and Retnla/ AAMacs (Fig. 6 E, bottom). 
WT and Retnla/ AAMacs also induced equivalent freq-
uencies of antigen-specific CD4+ T cells expressing IFN-  
(Fig. 6 F). Strikingly, OVA-pulsed Retnla/ AAMacs in-
duced a threefold increase in the frequency of IL-4+CD4+ T 
cells in comparison with WT AAMacs (Fig. 6 G). The ability 
AAMacs were left untreated or pulsed overnight with OVA 
protein and cocultured for 4 d with CFSE-labeled OVA-spe-
cific CD4+ T cells. When unpulsed, WT and Retnla/ 
AAMacs did not induce T cell proliferation (Fig. 6 E, top). 
There was equivalent antigen-specific T cell proliferation 
when OVA-specific CD4+ T cells were cocultured with 
Figure 7. RELM- binds to effector CD4+ Th2 cells, DCs, and F4/80+ macrophages. DO11-10/4get splenocytes were incubated with OVA protein, 
followed by recovery of cells at day 3 to determine which cell types bind RELM-. (A) Schematic diagram of the RELM- capture assay. (B) Flow cytom-
etry plot (side scatter [SSC] vs. RELM-/streptavidin [SAV]) showing frequency of live cells that bind rRELM-. (C) Frequency of F4/80+ macrophages 
(right), CD11c+ DCs (middle), and CD19+ B cells (left) that bind RELM-. (D) Frequency of CD4+ T cells that bind RELM- (top). (E) IL-4/GFP expression of 
RELM-–bound CD4+ T cells (black line) and RELM-–unbound CD4+ T cells (red histogram). Results are representative of three independent experiments.
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Surface staining for markers of B cells (CD19+), DCs 
(CD11c+F4/80), and macrophages (F4/80+CD11c) re-
vealed RELM- binding to DCs and macrophages but not B 
cells (Fig. 7 C). This observation is indicative of the capacity 
of RELM- to influence antigen-presenting cell populations. 
Given that RELM- acts to suppress CD4+ T cell–derived 
Th2 cytokines, we sought to determine if rRELM- bound 
directly to CD4+ T cells. The RELM- capture assay revealed 
the presence of a distinct population of RELM-–bound 
CD4+ T cells that was absent from the control assay (Fig. 7 D). 
Comparison of the IL-4/GFP expression of RELM-–un-
bound CD4+ T cells (Fig. 7 E, red histogram) with RELM-
–bound CD4+ T cells (Fig. 7 E, black histogram) revealed 
that RELM- preferentially bound effector CD4+ Th2 cells 
with 100% of the RELM-–bound CD4+ cells expressing 
IL-4/GFP. Collectively, these data implicate that the mecha-
nism by which RELM- suppresses Th2 cytokines may be 
dependent on binding and interactions with DCs, macro-
phages, and effector CD4+ Th2 cells.
RELM-–induced suppression of Th2 cytokine production  
is dependent on BTK signaling
Given that previous studies have demonstrated that RELM- 
can signal through the BTK (41), we sought to determine if the 
inhibition of Th2 cytokine production by RELM- was depen-
dent on BTK signaling by using a BTK inhibitor (LFM-A13) 
(41). Treatment of CFSE-labeled splenocytes that were activated 
with -CD3/-CD28 under Th2-permissive conditions with a 
BTK inhibitor did not affect CD4+ T cell proliferation or Th2 
cytokine production (Fig. S6). Furthermore, BTK inhibition of 
rRELM-–treated splenocyte cultures did not alter CD4+ T cell 
proliferation (Fig. 8 A). However, although rRELM- inhib-
ited the production of IL-5 and IL-13, as previously demon-
strated (Fig. 5), this suppressive effect was abrogated in the 
presence of the BTK inhibitor (Fig. 8 B). Because LFM-A13 
can also inhibit Jak2 kinase activity (42), it is possible that the ef-
fect of RELM- may be partly dependent on Jak2 kinase signal-
ing. Nevertheless, given the previous evidence showing that 
BTK is a binding partner for RELM- (41), these results impli-
cate BTK signaling as one mechanism by which RELM- 
of Retnla/ AAMacs to augment antigen-specific Th2 cell 
differentiation was confirmed by ELISA. Although equiva-
lent IFN- production was observed in cultures with WT 
and Retnla/ AAMacs, there was a threefold increase in IL-4 
secretion and a 10-fold increase in IL-5 secretion when OTII 
T cells were cocultured with OVA-pulsed Retnla/ AAMacs 
in comparison with WT AAMacs (Fig. 6 H). Collectively, 
these data demonstrate that the absence of AAMac-derived 
RELM- results in exaggerated production of antigen-spe-
cific Th2 cytokines by CD4+ T cells.
RELM- binds CD11c+ DCs, F4/80+ macrophages,  
and CD4+ Th2 effector cells
Given that rRELM- treatment of whole splenocyte cultures 
suppressed Th2 cytokine production and Retnla/ AAMacs 
promoted exaggerated antigen-specific CD4+ Th2 cell re-
sponses, we sought to determine if the immunomodulatory 
effects of RELM- were through direct effects on macro-
phages and/or CD4+ T cells. rRELM- treatment of purified 
CD4+ T cells activated with CD3/CD28 under Th2-per-
missive conditions did not affect cell proliferation or cytokine 
production (Fig. S4 A). Furthermore, pretreatment of BM-
Macs with rRELM- did not alter their ability to stimulate 
antigen-specific CD4+ T cell proliferation or Th2 cytokine 
production (Fig. S4 B). These data suggest that the immuno-
modulatory effects of RELM- are dependent on its com-
bined action on both macrophages and CD4+ T cells.
To test which cells bind RELM- and may be sensitive to 
its regulation, we designed a RELM- capture assay. Spleno-
cytes from OVA-specific IL-4 reporter mice (DO11-10/4get) 
that were stimulated for 3 d with OVA protein were incu-
bated with rRELM-, followed by detection of the RELM-
–bound cells with an anti–RELM- antibody (Fig. 7 A). 
In comparison with the control incubation with no recombi-
nant RELM-, there was a small but distinct population of 
cells that exhibited surface-bound RELM- (Fig. 7 B). Addi-
tional controls, which included incubation with the homolo-
gous protein rRELM- or the use of a rabbit isotype control 
for anti-RELM-, revealed little or no positive staining, con-
firming specificity of the RELM- binding assay (Fig. S5). 
Figure 8. Suppression of Th2 cytokine production by RELM- is dependent on BTK signaling. CFSE-labeled splenocytes were left untreated (UT) 
or stimulated with -CD3/-CD28 under Th2-permissive conditions, with or without (+/) 5 µg/ml rRELM-, or with or without an inhibitor for BTK (BTK 
inh.). (A) Frequency of CD4+ T cell proliferation at day 4. (B) IL-5 and IL-13 secretion by cells from A. Results (mean ± SEM; *, P< 0.05) are representative 
of two independent experiments.
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studies showing that RELM-+ AAMacs modulate CD4+ T 
cell function suggest that AAMacs present in the draining 
LNs may regulate CD4+ Th2 cell function in vivo. In addi-
tion to effects of AAMac-derived RELM- in the LNs, Sm 
egg challenge induced RELM- expression in the lung pa-
renchyma by AAMacs, airway epithelial cells, and eosino-
phils. Although the critical role for epithelial cells at mucosal 
surfaces as physical barriers to the external environment is 
well recognized, recent reports demonstrated that epithelial 
cells are also important modulators of innate and adaptive im-
mune responses at mucosal sites (49–51). In vitro studies 
demonstrated that human bronchial epithelial cells could in-
hibit T cell activation and proliferation (49), and eosinophils 
have been implicated in influencing effector Th2 cell recruit-
ment during allergic pulmonary inflammation (52). There-
fore, in addition to AAMac-mediated regulation, Th2 effector 
cells in the inflamed lung may be influenced by RELM- 
derived from airway epithelial cells and infiltrating eosino-
phils. The generation of cell lineage-specific Retnla/ mice 
will be the basis of future studies to elucidate the influence of 
RELM- derived from distinct cell types on the develop-
ment or progression of lung inflammation.
Munitz et al. (53) recently reported that RELM- was ex-
pressed by eosinophils and intestinal epithelial cells, but not 
macrophages, in the dextran sodium sulfate–induced colitis and 
that RELM- exacerbated intestinal inflammation, revealing 
complexity in RELM- function at different sites of inflamma-
tion. We and others have recently demonstrated a function for 
the related protein RELM- in promoting inflammation (38, 
54, 55), indicating a dichotomy in the function of this protein 
family at different mucosal sites. Although i.v. challenge with 
Sm eggs resulted in the antigen-specific activation of CD4+ 
Th2 cells and the recruitment and differentiation of RELM-+ 
AAMacs, the intestinal inflammation resulting from dextran so-
dium sulfate administration is caused by activation of innate im-
mune cells in response to the breakdown of the intestinal barrier. 
Thus, whether RELM- plays a beneficial or detrimental role 
in limiting inflammation is likely to be influenced by the im-
mune stimulus and the tissue site.
In addition to exaggerated expression of Th2 cytokines, 
Sm egg challenge also induced severe pulmonary endothelial 
inflammation in the absence of RELM-. Consistent with 
potential effects of RELM- in influencing endothelial in-
flammation, Daley et al. (28) recently demonstrated that pul-
monary arterial remodeling occurs as a direct consequence of 
CD4+ T cell–derived Th2 cytokines and is associated with 
the recruitment of RELM-+ macrophages in a model of 
antigen-specific airway inflammation. Additionally, previous 
studies showed that RELM- expression in the lung occurs 
in response to pulmonary stress, including hypoxia and injury 
(31, 32, 56), and rRELM- induced the expression of angio-
genic factors such as vascular endothelial growth factor and 
vascular endothelial cell adhesion molecule-1 (57, 58), lead-
ing to the hypothesis that RELM- may mediate lung vascu-
larization associated with pulmonary inflammation. Although 
vascularization is essential for leukocyte recruitment to the 
down-regulates Th2 cytokine production. Collectively with the 
exacerbated Th2 cytokine responses in Sm egg-challenged 
Retnla/ mice in vivo, these in vitro studies indicate that one 
immunoregulatory mechanism of action of AAMac-derived 
RELM- involves the direct action of RELM- on macro-
phages and CD4+ Th2 effector cells, resulting in the BTK-de-
pendent down-regulation of Th2 cytokine production.
DISCUSSION
The alternative activation of macrophages has been observed 
in a wide range of disease settings including chronic pulmo-
nary inflammation; however, the functions of AAMacs and 
AAMac-derived proteins in influencing disease development, 
progression, or resolution have remained controversial. In 
this study, we describe the generation of Retnla/ mice and 
use a model of Th2 cytokine-mediated pulmonary disease to 
demonstrate a previously unrecognized immunoregulatory 
role for RELM- in limiting Th2 cytokine-mediated inflam-
mation in the lung. After Sm egg challenge, Retnla/ mice 
exhibited elevated expression of Th2 cytokines and severe 
pulmonary inflammation compared with WT counterparts. 
Furthermore, in in vitro T cell differentiation assays, RELM- 
could bind DCs, macrophages, and CD4+ T cells, and it in-
hibited the production of CD4+ T cell–derived Th2 cyto-
kines in a BTK-dependent manner, suggesting that one 
mechanism through which AAMac-derived RELM- inhib-
its excessive Th2 cytokine-mediated inflammation in vivo 
may be through the regulation of CD4+ T cell responses.
In addition to an innate role in pathogen killing, there is 
increasing evidence that macrophages are recruited to a variety 
of inflammatory settings where they might participate in the 
down-regulation of inflammation and the subsequent tissue 
repair process (3, 19, 43). In the lung, alveolar macrophages 
are proposed to be critical suppressors of excessive inflamma-
tory responses, in part through the action of TGF- (44, 45). 
Additionally, macrophages activated by toll-like receptor liga-
tion and immune complexes can protect against lethal endo-
toxemia (46). In models of colitis, clodronate-mediated 
depletion of macrophages resulted in disease exacerbation (4), 
and adoptive transfer of macrophages from Sm-infected mice 
could limit intestinal inflammation (47).
Consistent with an antiinflammatory role for AAMacs, 
macrophage-specific deletion of the IL-4R in mice, which 
would prevent AAMac differentiation, resulted in lethal liver 
and intestinal inflammation after Sm infection (18). However, 
the molecular mechanisms through which AAMacs can regu-
late inflammatory responses in these diverse disease settings have 
remained poorly defined. In this paper, we propose a role for 
AAMacs in limiting excessive Th2 cytokine-induced pulmonary 
inflammation, in part through the production of RELM-.
One mechanism by which AAMac-derived RELM- 
limits the magnitude of the Sm egg-induced lung inflamma-
tory response is through action on CD4+ T cells to specifi-
cally inhibit the production of Th2 cytokines. Given previous 
studies demonstrating that AAMacs are present in the LNs 
draining the site of inflammation (24, 27, 48), our in vitro 
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5-TTGCCTGTGGATCTTGGGAG-3 and 5-TTCTCCCTATGTTT-
CCTAACC-3 (382 bp; WT allele). Heterozygous female offspring were 
backcrossed to the C57BL/6 background (n > 5 generations). Mice were 
maintained in a specific pathogen-free facility. Animal protocols were ap-
proved by the University of Pennsylvania Institutional Animal Care and Use 
Committee (IACUC), and all experiments were performed according to the 
guidelines of the University of Pennsylvania IACUC.
Analysis of immune cell compartments in Retnla/ mice. Spleens, 
thymi, and LN were isolated from 12–14-wk-old mice and single cell suspen-
sions were prepared. Cells were analyzed by flow cytometry with antibodies 
to CD4, CD8, CD3, DX5, B220, CD62L, CD44, and CD69 (eBioscience) 
using the Canto Flow cytometer (BD), followed by analysis using FlowJo 
software (Tree Star, Inc.). Cytometry plots depict log10 fluorescence. Cyto-
centrifuge preparations of cells from the BAL and PEC were prepared and 
stained with H&E (Thermo Fisher Scientific).
Sm egg granuloma model. WT C57BL/6 or Retnla/ mice were im-
munized i.p. with 5,000 Sm eggs followed by i.v. challenge with 5,000 eggs 
14 d later. Naive WT or Retnla/ mice were used as controls. For measure-
ment of BrdU incorporation, mice were injected with 0.8 mg BrdU (Sigma-
Aldrich) in PBS at days 3 and 1 before sacrifice. At day 8 after challenge, 
animals were euthanized, followed by cardiac bleeding for serum recovery. 
BAL cells were recovered for flow cytometric analysis or cytocentrifuge 
preparations. Lung tissue was recovered for RNA extraction, or lung disso-
ciation was performed to obtain single cell suspensions. For histology, lungs 
were inflated with 4% paraformaldehyde, embedded in paraffin, and 5-µm 
sections were used for staining with H&E, Masson’s trichrome, and IF. Mea-
surement of the egg-induced granulomas was performed as previously de-
scribed (65). For IF, sections were stained with rabbit polyclonal anti– 
RELM- (1:1,000; PeproTech), biotinylated anti-mannose receptor (1:100; 
AbD Serotec), anti-CC10 (1:400; Santa Cruz Biotechnology, Inc.), anti–si-
glec-F (1:100; BD), and anti–IL-4R (1:200; eBioscience), followed by in-
cubation with the appropriate fluorochrome-conjugated secondary antibodies 
(Jackson ImmunoResearch Laboratories) and counterstaining with DAPI 
(Invitrogen). Single cell suspensions from the lung were prepared by diges-
tion for 30 min at 37°C with 1 mg/ml collagenase d (Roche) and 20 µg/ml 
DNase Type IV (Sigma-Aldrich) in complete media, followed by a Percoll 
gradient (Thermo Fisher Scientific). For intracellular RELM- staining, 
cells were incubated with 10 µg/ml brefeldin A for 6 h at 37°C, fixed, per-
meabilized (Cytofix/Cytoperm kit; BD), and then stained with anti–RELM- 
(1:200), followed by incubation with Alexa 488–conjugated anti–rabbit an-
tibody (1:400; Invitrogen). Western blot analysis for RELM- was per-
formed by incubation with anti–RELM- (1:1,000), and secondary staining 
was performed with peroxidase-conjugated anti–rabbit antibody (1:2,000; 
Jackson ImmunoResearch Laboratories).
Analysis of lymphocyte responses. Draining mediastinal LN cells were 
stimulated ex vivo by incubation for 4 h with 50 ng/ml PMA, 750 ng/ml 
ionomycin, and 10 µg/ml Brefeldin A (all obtained from Sigma-Aldrich), 
followed by surface staining for CD4 and intracellular staining for IFN-, 
IL-5, and IL-13 (eBioscience). LN cells were plated at 1.5 million cells/well 
in complete medium alone or with 20 µg/ml of soluble Sm egg antigen. Su-
pernatants were assayed for IL-4, IL-5, and IL-13 using standard sandwich 
ELISA protocols. Serum dilutions were assayed by ELISA for total IgE using 
OptEIA IgE kit (BD) or for antigen-specific IgG1 using Sm egg antigen–
coated plates (5 µg/ml). For in vitro assays, single cell suspensions from pe-
ripheral LN and spleen were CFSE labeled (5 µg/ml; Invitrogen) and cultured 
with 1 µg/ml each of -CD3/-CD28 (eBioscience) alone or in the pres-
ence of 1–40 µg/ml rRELM- (PeproTech). Th2-permissive conditions 
were the following: 40 ng/ml rIL-4 (R&D Systems), 50 µg/ml of anti–IL-12 
(C17.8), and 50 µg/ml of anti–IFN- (XMG 1.2). Cells were recovered at 
day 1 for surface expression analysis of CD25 and CD69 on CD4+ T cells. 
Supernatants were recovered at day 4 for cytokine measurement by ELISA. 
25 µM of the inhibitor LFM-A13 (EMD) was used to inhibit BTK signaling. 
site of inflammation, it also participates in the subsequent heal-
ing process, allowing the recruitment and activation of fibro-
blasts that will mediate tissue repair and wound contraction. 
Our findings that Retnla/ mice exhibit exacerbated Sm egg-
induced arterial inflammation suggest that rather than promot-
ing disease, the angiogenic properties of RELM- are critical 
to mediate tissue repair and lung regeneration in response to 
Sm egg-induced lung injury. In addition to activation during 
an adaptive Th2 cytokine response, the recruitment of AAMacs 
also occurs as an immediate innate response to injury (20, 59). 
Thus, through the production of RELM-, AAMacs may 
play a pivotal role in mediating tissue repair after injury.
Although the receptor for RELM- is unknown at pres-
ent, we have demonstrated that hematopoietic cells are re-
sponsive to RELM- and that RELM- can bind to DCs, 
macrophages, and CD4+ effector Th2 cells, suggesting that the 
immunomodulatory effects of RELM- observed after Sm egg 
challenge may be through direct action on DCs, AAMacs, and 
CD4+ T cells. Furthermore, we show that the suppression of 
Th2 cytokine production mediated by RELM- is dependent 
on BTK signaling, which is consistent with previous studies 
demonstrating that RELM- can bind BTK (58). BTK, a 
non–receptor-associated tyrosine kinase of the Tec family, is a 
downstream target of the phosphatidylinositol 3-kinase (PI3K) 
pathway (60). Interestingly, mice deficient in the Src homol-
ogy 2–containing inositol-5phosphatase (SHIP), a negative 
regulator of the PI3K pathway, exhibited a similar phenotype 
to Sm egg-challenged Retnla/ mice, including increased Th2 
cytokine-associated lung fibrosis (21, 61), suggesting that 
through its modulation of BTK signaling, RELM- may act in 
a similar manner to SHIP.
Comparative phylogenomic analysis of the RELM family 
has revealed the existence of two closely related human RELM 
proteins: resistin and RELM- (24, 25, 33). Although mouse 
resistin expression is restricted to adipocytes (62), human resistin 
shows a similar expression pattern to that of mouse RELM- 
and is expressed by leukocytes and myeloid cells recruited in in-
flammatory diseases including rheumatoid arthritis and diabetes 
(30, 63). Thus, the investigation of whether human resistin 
shares similar properties to RELM- and can negatively regu-
late CD4+ Th2 cell responses warrants further investigation. In 
summary, the data presented in this paper identify a previously 
unrecognized role for AAMac-derived RELM- in regulating 
CD4+ Th2 cell–mediated lung inflammation. Because activa-
tion and recruitment of AAMacs is a dominant feature in inflam-
matory responses associated with diseases as diverse as cancer, 
diabetes, and asthma, the manipulation of RELM- expression 
may offer novel therapeutic strategies for the treatment of mul-
tiple inflammatory conditions.
MATERIALS AND METHODS
Mice. WT C57BL/6 and C3H/HeJ were purchased from The Jackson 
Laboratory. OTII transgenic mice and DO11-10/4get transgenic mice were 
bred at the University of Pennsylvania. VelociGene technology was used to 
generate the Retnla/ mice (64) (Fig. 1 A). For genotyping, a PCR-based 
method was used with primers 5-TCATTCTCAGTATTGTTTTGCC-3 
and 5-TTCTCCCTATGTTTCCTAACC-3 (384 bp; / allele) or primers 
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